
Taiwanese developer of microfluidic testing equipment for early cancer screening.
Industry: Health Care
Latest Trade: $0.38 -0.01 (-1.9%)
First Day Return: -8.8%
Return from IPO: -90.4%
Industry: Health Care

| IPO Data | |
|---|---|
| IPO File Date | 05/22/2023 |
| Offer Price | $4.00 |
| Price Range $4.00 - $6.00 | |
| Offer Shares (mm) | 1.6 |
| Deal Size ($mm) | $7 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 03/05/2025 |
| Offer Price | $4.00 |
| Price Range $4.00 - $6.00 | |
| Offer Shares (mm) | 1.6 |
| Deal Size ($mm) | $7 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| Underwriters |
|---|
| Craft Capital Management |
| Company Data | |
|---|---|
| Headquarters | Tainan, Taiwan |
| Founded | 2014 |
| Employees at IPO | 40 |
| Website www.advanbiomed.com | |